Although there are reports in lung cancer and melanoma models that suggest LKB1 as a regulator of tumor progression and invasion through the remodeling of the tumor matrix, its role in matrix remodeling has yet to be fully explored in breast cancer (Gao et al., 2010b; Chan et al., 2014). Here, STK11 is linked to lung cancer.